文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

肌球蛋白隔离调控肌节功能、心肌细胞能量与代谢,揭示肥厚型心肌病发病机制

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
PubMed 文献 · Circulation · 2020-01-27

研究探讨肌球蛋白构象状态(SRX与DRX)在能量保守与收缩输出间的平衡,发现致病性错义变异破坏SRX构象、增加DRX比例,导致收缩增强但松弛受损、能量应激及不良临床结局;变构调节剂可纠正表型。

要点

  • 肌球蛋白SRX构象最大化能量保守,DRX构象支持横桥形成与ATP消耗。
  • 致病性肌球蛋白变异不稳定SRX、增加DRX,与心衰和心律失常风险升高相关。
  • 变构调节剂恢复SRX构象可纠正细胞收缩与代谢表型。

核心结论

  • 肌球蛋白构象建立工作-能量平衡,对终身细胞稳态和心脏功能至关重要。
  • SRX构象不稳定促进收缩异常、形态与代谢重塑及不良临床结局。
  • 治疗性再稳定可纠正细胞收缩与代谢表型,可能限制不良结局。

研究设计与样本

  • 使用ATP结合试验评估健康啮齿类与人类心脏中肌球蛋白SRX与DRX构象比例。
  • 在基线、冬眠降低血流动力学需求及致病性HCM变异条件下比较构象比例。
  • 评估收缩力、松弛、心肌细胞形态与代谢,并测试变构调节剂效果。
  • 分析HCM患者中未知临床意义肌球蛋白变异的位置与功能后果及临床关联。

主要发现

  • 冬眠增加SRX构象比例,致病性变异不稳定SRX并增加DRX比例。
  • DRX增加增强心肌细胞收缩力,但损害松弛并诱发肥厚重塑与能量应激。
  • 不稳定肌球蛋白构象的未知意义变异与HCM患者心衰和心律失常发生率较高相关。

临床怎么用

  • 肌球蛋白构象状态可作为HCM病理生理评估的潜在靶点。
  • 变构调节剂再稳定SRX构象可能改善收缩与代谢表型。
  • 未知意义变异的结构定位有助于预测心衰和心律失常风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by pathogenic variants in sarcomere protein genes that evoke hypercontractility, poor relaxation, and increased energy consumption by the heart and increased patient risks for arrhythmias and heart failure. Recent studies show that pathogenic missense variants in myosin, the molecular motor of the sarcomere, are clustered in residues that participate in dynamic conformational states of sarcomere proteins. We hypothesized that these conformations are essential to adapt contractile output for energy conservation and that pathophysiology of HCM results from destabilization of these conformations. METHODS: We assayed myosin ATP binding to define the proportion of myosins in the super relaxed state (SRX) conformation or the disordered relaxed state (DRX) conformation in healthy rodent and human hearts, at baseline and in response to reduced hemodynamic demands of hibernation or pathogenic HCM variants. To determine the relationships between myosin conformations, sarcomere function, and cell biology, we assessed contractility, relaxation, and cardiomyocyte morphology and metabolism, with and without an allosteric modulator of myosin ATPase activity. We then tested whether the positions of myosin variants of unknown clinical significance that were identified in patients with HCM, predicted functional consequences and associations with heart failure and arrhythmias. RESULTS: Myosins undergo physiological shifts between the SRX conformation that maximizes energy conservation and the DRX conformation that enables cross-bridge formation with greater ATP consumption. Systemic hemodynamic requirements, pharmacological modulators of myosin, and pathogenic myosin missense mutations influenced the proportions of these conformations. Hibernation increased the proportion of myosins in the SRX conformation, whereas pathogenic variants destabilized these and increased the proportion of myosins in the DRX conformation, which enhanced cardiomyocyte contractility, but impaired relaxation and evoked hypertrophic remodeling with increased energetic stress. Using structural locations to stratify variants of unknown clinical significance, we showed that the variants that destabilized myosin conformations were associated with higher rates of heart failure and arrhythmias in patients with HCM. CONCLUSIONS: Myosin conformations establish work-energy equipoise that is essential for life-long cellular homeostasis and heart function. Destabilization of myosin energy-conserving states promotes contractile abnormalities, morphological and metabolic remodeling, and adverse clinical outcomes in patients with HCM. Therapeutic restabilization corrects cellular contractile and metabolic phenotypes and may limit these adverse clinical outcomes in patients with HCM.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Toepfer CN, Garfinkel AC, Venturini G, et al. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy. Circulation. 2020. PMID: 31983222. doi:10.1161/CIRCULATIONAHA.119.042339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。